Table 1.
Clinical characteristic of the 5564 subjects included in the study and eligible for analysis.
All | T2D | AP | MI | Stroke | No T2D and/or CVD | |
---|---|---|---|---|---|---|
Individuals (n) | 5,564 | 1,590a | 769a | 672a | 500a | 3,027a |
Gender (male/female) | 2,754/2,810 | 754/836 | 435/334 | 475/197 | 256/244 | 1,424/1,603 |
Age (years at examination) | 60.4 ± 17.1 | 68.1 ± 12.0 | 72.4 ± 9.2 | 70.7 ± 10.3 | 70.8 ± 11.0 | 53.2 ± 17.6 |
BMI (kg/m2) | 27.3 ± 4.4 | 29.2 ± 4.8 | 28.0 ± 4.3 | 27.5 ± 3.9 | 27.4 ± 3.9 | 26.4 ± 4.1 |
Ever smoked (yes/no) | 2,600/2,964 | 647/943 | 345/424 | 367/305 | 241/259 | 1,468/1,559 |
Nonfasting serum glucoseb (mmol/L) | 6.6 ± 3.1 | 9.6 ± 4.2 | 7.6 ± 3.6 | 7.2 ± 3.5 | 6.6 ± 2.7 | 5.4 ± 1.2 |
Serum triglyceride (mmol/L) | 2.0 ± 1.3 | 2.5 ± 1.6 | 2.4 ± 1.6 | 2.3 ± 1.3 | 2.2 ± 1.5 | 1.8 ± 1.1 |
Serum cholesterol (mmol/L) | 6.1 ± 1.3 | 6.2 ± 1.3 | 6.3 ± 1.3 | 6.2 ± 1.3 | 6.4 ± 1.3 | 6.0 ± 1.3 |
Serum HDL cholesterol (mmol/L) | 1.3 ± 0.4 | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.3 ± 0.4 | 1.4 ± 0.4 |
Heart rate (bpm) | 73.6 ± 13.6 | 75.5 ± 14.5 | 6.8 ± 13.6 | 67.6 ± 13.3 | 72.1 ± 13.4 | 74.1 ± 12.8 |
Type 2 diabetes (n, %) | 1,590 (28.6%) | 1,590 (100%) | 326 (42.4%) | 212 (31.5%) | 110 (22%) | n/a |
Myocardial infarction (n, %) | 672 (12.1%) | 212 (13.3%) | 357 (46.9%) | 672 (100%) | 83 (16.6%) | n/a |
Stroke (n, %) | 500 (9.0%) | 110 (6.9%) | 115 (15.1%) | 357 (53.1%) | 500 (100%) | n/a |
Angina pectoris (n, %) | 769 (13.7%) | 326 (20.5%) | 769 (100%) | 83 (12.4%) | 115 (23%) | n/a |
Values are presented as means ± SD or number (%). aSome individuals have more than one outcome (for example MI + diabetes); hence, the sum of these column counts does not match the total counts of individuals. bOnly nonfasting glucose measures were available for participants in the HUNT2 cohort. MI denotes previous myocardial infarction. Abbreviations: T2D, Type 2 diabetes; AP, angina pectoris; MI, myocardial infarction; CVD, cardiovascular disease; bpm, beats per minute.